Risk of Acetylsalicylic Acid (ASA) in Patients with Asthma
Acetylsalicylic acid (ASA) is contraindicated in patients with asthma who have a history of ASA sensitivity due to the risk of potentially life-threatening bronchospasm. 1, 2
Prevalence and Mechanism
- Approximately 10% of adults with asthma and a smaller proportion of children experience respiratory deterioration when taking ASA or other NSAIDs 3
- The prevalence of aspirin hypersensitivity ranges from 0.6% to 2.5% in the general population and from 4.3% to 11% in adult asthmatics 4
- ASA-induced asthma is characterized by overproduction of cysteinyl-leukotrienes (Cys-LTs) and intense eosinophilic inflammation of nasal and bronchial tissues 5
- The mechanism involves inhibition of cyclooxygenase enzymes, leading to overproduction of leukotrienes and removal of the bronchodilator effect of prostaglandin E2 6
High-Risk Patients
- Patients with the following features are at highest risk for ASA-induced bronchospasm:
- The classic presentation (Samter's Triad) includes: aspirin-induced bronchial asthma, aspirin sensitivity, and chronic rhinosinusitis with nasal polyps 4
Clinical Presentation
- Within 3 hours of ASA ingestion, sensitive individuals may develop:
- In severe cases, a single therapeutic dose can provoke:
Recommendations for ASA Use in Asthma
- ASA and other NSAIDs are absolutely contraindicated in patients with known ASA intolerance 1, 2
- The FDA drug label specifically warns that ASA may cause asthma (wheezing) and should not be used by patients with asthma without consulting a doctor 2
- Patients with uncontrolled or severe asthma should avoid ASA due to increased risk of severe exacerbations 1
- For patients with asthma who have never used NSAIDs before, medical supervision is recommended for first-time use 3
Alternative Approaches
- Acetaminophen (paracetamol) is generally considered safer for patients with ASA-sensitive asthma, though a small proportion may still experience respiratory deterioration with high doses 3
- For patients who absolutely require ASA therapy (e.g., for cardiovascular disease), options include:
Special Considerations
- ASA desensitization can be successful initially but sensitivity may recur despite continuous therapy 7
- Patients with both cardiovascular disease and asthma require careful risk-benefit assessment when considering ASA therapy 1
- Patients with asthma who regularly use NSAIDs without problems can continue but should be warned that intolerance can develop later in life 3
Diagnostic Approach
- For patients with suspected ASA sensitivity, oral, inhaled, nasal, or intravenous aspirin challenge tests can be performed 6
- These tests should only be conducted in facilities with experienced physicians and emergency treatment available 6
ASA-induced asthma represents a significant risk for certain asthmatic patients. Healthcare providers should carefully assess the risk-benefit ratio before prescribing ASA to patients with asthma, particularly those with high-risk features such as nasal polyps or severe asthma.